** Shares in Dutch speciality chemicals maker IMCD NV IMCD.AS are down more 8.3% after the company announced a transition in its CEO
** Valerie Diele-Braun will step down as CEO 'for personal reasons,' effective right away, and is replaced by Marcus Jordan
** Jefferies notes that change comes one day prior to their Q12025 results for which consensus expected a 13% higher EBITDA, while competitor Azelis AZE.BR just reported an EBITDA 9% below consensus
** KBC Securities says this transition has "no impact on our investment case," nor "on our business case" - maintaining a "buy" rating and TP of EUR 154
** Shares on track for its worst day since mid June 2022
** The company is among the worst performers on STOXX 600 index .STOXX
(Reporting by Johan Bodinier in Gdansk)
((johangeorgesroger.bodinier@thomsonreuters.com))